Assignee
AKIRABIO INC
US·1 granted patent·3 pending applications·1 citations·filing 2021–2024
Top patents by PatentIndex Score
4 records- 0179US11938143B2Compositions comprising 2′-deoxycytidine analogs and use thereof for the treatment of sickle cell disease, thalassemia, and cancersAKIRABIO INC·Filed 2022·Granted Mar 26, 2024·1 cites·20 claims
- 0261US2025000887A1Compositions comprising 2'-deoxycytidine analogs and use thereof for the treatment of sickle cell disease, thalassemia, and cancersAKIRABIO INC·Filed 2024·Application pending·0 cites
- 0351US2023123277A1Compositions comprising 2'-deoxycytidine analogs and use thereof for the treatment of sickle cell disease and thalassemiaAKIRABIO INC·Filed 2022·Application pending·0 cites
- 0442US2023055298A1Compositions comprising 2'-deoxycytidine analogs and use thereof for the treatment of sickle cell disease, thalassemia, and cancersAKIRABIO INC·Filed 2021·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →